Inoviq Ltd has released a press release.
Voluntary Suspension
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Inoviq
- Capital Raising
- Israeli Patent Issued in Bard1 Core Patent Family
- Additional BARD1 Ovarian Test Results
- Grant of Japanese Patent
- Results of BARD1 ovarian cancer study
Later from Inoviq
- Contract Development Agreement Signed
- Improved Performance of BARD1 Ovarian Test
- US Patent Issued Protecting BARD1 Ovarian Test
- Quarterly Activities Report and Appendix 4C
- Appendix 4E
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq